Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	n.A.	-183.37	n.A.
Graham Fair Price	n.A.	6.44	n.A.
PEG	-74.95	-0.16	0.64
Price/Book	100.00	5.48	0.00
Price/Cash Flow	-100.00	-15.19	0.00
Prices/Earnings	47.11	-16.04	-30.32
Price/Sales	-47.07	26.61	50.27
Price/FCF	-100.00	-15.19	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	65.48	-0.19	-0.55
Operating Margin	-8.17	-0.39	-0.36
ROA	-100.00	-0.04	0.00
ROE	0.00	-0.09	-100.00
ROIC	0.00	-0.05	-100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.50	-1.16	130.15
EPS QOQ	0.47	-1.00	111.11
FCF QOQ	1.00	0.00	inf
Revenue QOQ	-0.28	1.00	255.15
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	n.A.	48.21	n.A.
Days Sales Outstanding (DSO)	n.A.	70.14	n.A.
Inventory Turnover	0.00	1.87	100.00
Debt/Capitalization	0.00	0.38	100.00
Quick Ratio	0.00	1.55	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	n.A.	4.64	n.A.
Cash	n.A.	1.96	n.A.
Capex	0.00	-1.40	-100.00
Free Cash Flow	0.00	-1.68	-100.00
Revenue	0.48	0.96	99.51
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	1.96	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	n.A.	-10.59	n.A.
Naive Interpretation	Member

06 - Financial Health · Weak

Rating